Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder

Pediatrics

Volumn 124, Issue 2, 2009, Pages 580-589

  Brinkman, William B ^a   Sherman, Susan N ^b   Zmitrovich, April R ^a   Visscher, Marty O ^a   Crosby, Lori E ^a   Phelan, Kieran J ^a   Donovan, Edward F ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b SNS Research   (United States)

Author keywords

ADHD; Adherence; Family self management; Parent decision making; Treatment

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; DECISION MAKING; FAMILY ASSESSMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENT COUNSELING; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DECISION MAKING; FEMALE; FOCUS GROUPS; HOSPITALS, PEDIATRIC; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OHIO; PARENTS; REFERRAL AND CONSULTATION; TREATMENT OUTCOME; UNCERTAINTY; YOUNG ADULT;

EID: 67749135431     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2569     Document Type: Article

References (57)

1. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857-864
2. Anastopoulos AD, Guevremont DC, Shelton TL, DuPaul GJ. Parenting stress among families of children with attention deficit hyperactivity disorder. J Abnorm Child Psychol. 1992;20(5):503-520
3. Podolski CL, Nigg JT. Parent stress and coping in relation to child ADHD severity and associated child disruptive behavior problems. J Clin Child Psychol. 2001;30(4):503-513
4. Harborne A, Wolpert M, Clare L. Making sense of ADHD: a battle for understanding? Parents' views of their children being diagnosed with ADHD. Clin Child Psychol Psychiatry. 2004;9(3):327-339
5. Singh I. Doing their jobs: mothering with Ritalin in a culture of mother-blame. Soc Sci Med. 2004;59(6):1193-1205
6. Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R. Stimulant treatment over 5 years: effects on growth. J Am Acad Child Adolesc Psychiatry. 2006;45(4):415-421
7. Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: friends or foes? Harv Rev Psychiatry. 2001;9(5):223-233
8. Singh I. Boys will be boys: fathers' perspectives on ADHD symptoms, diagnosis, and drug treatment. Harv Rev Psychiatry. 2003;11(6):308-316
9. dosReis S, Mychailyszyn MP, Myers M, Riley AW. Coming to terms with ADHD: how urban African-American families come to seek care for their children. Psychiatr Serv. 2007;58(5):636-641
10. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children With ADHD. Arch Gen Psychiatry. 1999;56(12):1073-1086
11. Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attentiondeficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159(6):572-578
12. Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics. 2003;111(2):237-243
13. Leslie LK, Weckerly J, Landsverk J, Hough RL, Hurlburt MS, Wood PA. Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. J Am Acad Child Adolesc Psychiatry. 2003;42(12):1433-1442
14. Stevens J, Harman JS, Kelleher KJ. Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol. 2005;15(1):88-96
15. Visser SN, Lesesne CA, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics. 2007;119(suppl 1): S99-S106
16. Sanchez RJ, Crismon ML, Barner JC, Bettinger T, Wilson JP. Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy. 2005;25(7): 909-917
17. Giacomini MK, Cook DJ. Users' guides to the medical literature: XXIII. Qualitative research in health care A: are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 2000; 284(3):357-362
18. Sofaer S. Qualitative methods: what are they and why use them? Health Serv Res. 1999;34(5 pt 2):1101-1118
19. Strange K, Zyzanski S. Integrating qualitative and quantitative methods. Fam Med. 1989;21(6): 448-451
20. Glaser B, Strauss A. The Constant Comparitive Methods of Qualitative Analysis: Discovery of Grounded Theory. New York, NY: Aldine de Gruyter; 1967
21. Patton MQ. Qualitative Research and Evaluation Methods. 3rd ed. Thousand Oaks, CA: Sage Publications; 2002
22. Patton MQ. Enhancing the quality and credibility of qualitative analysis. Health Serv Res. 1999;34(5 pt 2):1189-1208
23. Henker B, Whalen CK. The many messages of medication: hyperactive children's perceptions and attributions. In: The Ecosystem of the "Sick" Child. New York: Academic Press, Inc; 1980
24. Firestone P. Factors associated with children's adherence to stimulant medication. Am J Orthopsychiatry. 1982;52(3):447-457
25. Liu C, Robin AL, Brenner S, Eastman J. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder. Pediatrics. 1991;88(3):560-565
26. Klasen H. A name, what's in a name? The medicalization of hyperactivity, revisited. Harv Rev Psychiatry. 2000;7(6):334-344
27. Bussing R, Gary FA, Mills TL, Garvan CW. Parental explanatory models of ADHD: gender and cultural variations. Soc Psychiatry Psychiatr Epidemiol. 2003;38(10):563-575
28. Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2003;24(3):155-162
29. Arcia E, Fernandez MC, Jaquez M. Latina mothers' stances on stimulant medication: complexity, conflict, and compromise. J Dev Behav Pediatr. 2004;25(5):311-317
30. Bussing R, Koro-Ljungberg ME, Gary F, Mason DM, Garvan CW. Exploring help-seeking for ADHD symptoms: a mixed-methods approach. Harv Rev Psychiatry. 2005;13(2):85-101
31. dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R. Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community. J Behav Health Serv Res. 2006;33(4):423-430
32. McLeod JD, Fettes DL, Jensen PS, Pescosolido BA, Martin JK. Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. Psychiatr Serv. 2007;58(5): 626-631
33. Leslie LK, Plemmons D, Monn AR, Palinkas LA. Investigating ADHD treatment trajectories: listening to families' stories about medication use. J Dev Behav Pediatr. 2007;28(3):179-188
34. Olaniyan O, dosReis S, Garriett V, et al. Community perspectives of childhood behavioral problems and ADHD among African American parents. Ambul Pediatr. 2007;7(3):226-231
35. Johnston C, Hommersen P, Seipp C. Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics. Behav Ther. 2008;39(1):22-32
36. Leslie LK, Weckerly J, Plemmons D, Landsverk J, Eastman S. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics. 2004;114(1):129-140
37. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8): 922-928
38. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559-567
39. Hansen DL, Hansen EH. Caught in a balancing act: parents' dilemmas regarding their ADHD child's treatment with stimulant medication. Qual Health Res. 2006;16(9):1267-1285
40. Berger I, Dor T, Nevo Y, Goldzweig G. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives. J Child Neurol. 2008;23(9):1036-1042
41. The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004;113(4):762-769
42. Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007;46(8):1015-1027
43. Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med. 2006;354(14):1445-1448
44. Wilens TE, Prince JB, Spencer TJ, Biederman J. Stimulants and sudden death: what is a physician to do? Pediatrics. 2006;118(3):1215-1219
45. Biederman J, Spencer TJ, Wilens TE, Prince JB, Faraone SV. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1147-1150
46. Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation. 2008;117(18):2407-2423
47. Perrin JM, Friedman RA, Knilans TK. Cardiovascular monitoring and stimulant drugs for attentiondeficit/ hyperactivity disorder. Pediatrics. 2008;122(2):451-453
48. Epstein JN, Rabiner D, Johnson DE, et al. Improving attention-deficit/ hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial. Arch Pediatr Adolesc Med. 2007;161(9):835-840
49. Epstein JN, Langberg JM, Lichtenstein PK, Mainwaring BA, Luzader CP, Stark LJ. Community-wide intervention to improve the attention-deficit/ hyperactivity disorder assessment and treatment practices of community physicians. Pediatrics. 2008;122(1):19-27
50. Gardner W, Kelleher KJ, Pajer K, Campo JV. Follow-up care of children identified with ADHD by primary care clinicians: a prospective cohort study. J Pediatr. 2004;145(6):767-771
51. Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60-73
52. Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160(6):1071-1077
53. American Academy of Pediatrics, Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108(4):1033-1044
54. Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007; 46(8):1003-1014
55. Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children With ADHD (MTA): part II: supporting details. J Atten Disord. 2008;12(1):15-43
56. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921
57. Institute for Clinical Systems Improvement. Diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. Available at: www.icsi.org/adhd/adhd-2300.html. Accessed June 1, 2008